PFSAProfusa Inc. Common Stock
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee O…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens Profusa (NASDAQ:PFSA) reported progress toward satisfying conditions tied to its potential G3 Vision Labs acquisition, while second-quarter 2026 results showed a widening net loss and limited cash resources. The company is pursuing debt-to-equity exchanges and other balance-sheet changes as it works toward potentially exercising its option to acquire the commercial-stage diagnostics business. | ||
 Profusa vies for potential G3 Vision Labs acquisition If the acquisition goes ahead, Profusa will add several routine chemistry, toxicology and pathology diagnostic offerings to its portfolio. | ||
 Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes Profusa (NASDAQ:PFSA) has signed a non-binding term sheet to acquire a commercial-stage diagnostics company with estimated 2025 net revenue of approximately $111 million, while also reshaping its executive leadership as it pivots toward a diagnostics-focused business model. Key Investor TakeawaysProfusa (NASDAQ:PFSA) signed a non-binding term sheet to acquire a commercial-stage diagnostics company. | ||
Sector Update: Health Care Stocks Climb Late Afternoon Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index up 1.8% and the Hea | MMT Newswires | |
Sector Update: Health Care Stocks Higher Thursday Afternoon Health care stocks rose Thursday afternoon, with the NYSE Health Care Index up 1.4% and the Health C | MMT Newswires | |